$NUVB 3 SEC Filings

Filed On	Filing
09 Oct 2024	Form 3: Sauvage Philippe, Chief Financial Officer No securities owned
11 Apr 2024	Form 3: Cui Xiangmin, Director No securities owned
11 Apr 2024	Form 3: Wang Junyuan Jerry, Director No securities owned
02 Apr 2024	Form 3: Sjogren Colleen, Chief Commercial Officer Holds 25,000 shares of Class A Common Stock
10 Jan 2024	Form 3: Mashal Robert, Director No securities owned
27 Nov 2023	Form 3: Makunje Moses, See Remarks Holds 10,612 shares of Class A Common Stock
19 Jul 2022	Form 3: Liu Dongfang, Chief Medical Officer Holds 0 shares of No securities owned.
25 May 2022	Form 3: Wentworth Kerry, Chief Regulatory Officer Holds 0 shares of No securities owned.
03 Jun 2021	Form 3: Hanley David C., Chief Technical Operations No securities owned
12 Feb 2021	Form 3: Omega Fund V, L.p., 10% owner and 6 others Holds 0 shares of No securities owned.
12 Feb 2021	Form 3: Vernon W Anthony, Director Holds 0 shares of No securities owned.
12 Feb 2021	Form 3: Falberg Kathryn E, Director Holds 0 shares of No securities owned.
12 Feb 2021	Form 3: Blickenstaff Kim D, Director Holds 0 shares of No securities owned.
12 Feb 2021	Form 3: Bazemore Robert B, Director Holds 0 shares of No securities owned.
12 Feb 2021	Form 3: Welch Daniel G, Director Holds 0 shares of No securities owned.
12 Feb 2021	Form 3: Markel Stacy, SVP, Human Resources Holds 0 shares of No securities owned.
12 Feb 2021	Form 3: Templeman Thomas, SVP, Pharmaceutical Ops Holds 0 shares of No securities owned.
12 Feb 2021	Form 3: Hattersley Gary, Chief Scientific Officer Holds 0 shares of No securities owned.
12 Feb 2021	Form 3: Yurasov Sergey, Chief Medical Officer Holds 0 shares of No securities owned.
12 Feb 2021	Form 3: Fox Jennifer A., Chief Financial Officer Holds 0 shares of No securities owned.

Comments